10X GENOMICS, INC. - Annual Financials - Income Statement (SEC)
Updated on January 2, 2026.
Related Topics: SEC Topic List.
Data Source: SEC.
See details in table below.
You can see similar for other companies.
10X GENOMICS, INC. - Annual Income Statement
(In Thousands of USD, Except Per Share Amounts)
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| Revenue | 610785 | 618727 | 516409 |
| Cost of revenue | 196303 | 209414 | 120386 |
| Gross profit | 414482 | 409313 | 396023 |
| Research and development | 264698 | 270332 | 265667 |
| In-process research and development | 0 | 60980 | 0 |
| Selling, general and administrative | 344343 | 343330 | 298300 |
| Total operating expenses | 609041 | 674642 | 563967 |
| Loss from operations | -194559 | -265329 | -167944 |
| Interest income | 18448 | 16906 | 6647 |
| Interest expense | 4 | 33 | 476 |
| Other expense, net | -1585 | -307 | -198 |
| Total other income | 16859 | 16566 | 5973 |
| Loss before provision for income taxes | -177700 | -248763 | -161971 |
| Provision for income taxes | 4927 | 6336 | 4029 |
| Net loss | -182627 | -255099 | -166000 |
| Basic Earnings Per Share | -1.52 | -2.18 | -1.46 |
| Diluted Earnings Per Share | -1.52 | -2.18 | -1.46 |
| Basic Weighted Average Shares Outstanding | 120451.55 | 117165.036 | 113858.684 |
| Diluted Weighted Average Shares Outstanding | 120451.55 | 117165.036 | 113858.684 |
Popular Topics:
Find us
Copyright © Beautify Data LLC. All Rights Reserved.